Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation (Q80952560)
Jump to navigation
Jump to search
scientific article published on 01 November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation |
scientific article published on 01 November 2004 |
Statements
Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation (English)
1 November 2004